• Bone Transport, TGF-β1, and Diabetic Wound Repair

  2026-09-16

  A 2026 rat study identifies TGF-β1/TGFBR1 signaling as a mechanistic link between bone transport, angiogenesis, immune regulation, and diabetic foot-ulcer repair. Its combined proteomic, molecular, histological, and intervention-based design provides a framework for testing whether pathway modulation contributes to the wound-healing effects of distraction osteogenesis.

• Triamcinolone B1859: Practical Research Guide

  2026-09-16

  Triamcinolone (SKU B1859) provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. It is intended for scientific research workflows, not diagnostic, therapeutic, or clinical use, and requires careful attention to DMSO preparation, storage, and assay controls.

• PCN, Gut Microbiota, and YAP in Sepsis

  2026-09-15

  A 2026 study shows that Pregnenolone-16α-carbonitrile (PCN) protects mice from sepsis-associated liver injury through a gut microbiota-dependent mechanism involving Yes-associated protein (YAP) activation. Antibiotic depletion and fecal microbiota transplantation experiments move the findings beyond a simple hepatic PXR model and provide a framework for studying gut–liver signaling in sepsis.

• AMPK–SQSTM1 Feedback Under Metabolic Stress

  2026-09-15

  A 2024 Autophagy study identifies a double-positive feedback loop in which AMPK and SQSTM1/p62 reinforce one another during metabolic stress. The mechanism links lysosomal deacidification, TFEB/TFE3 regulation, ROS- and calcium-dependent TAK1 activation, and coordinated AMPK–NRF2 antioxidant defense, with implications for STK11- and KEAP1-altered lung cancer.

• Y-27632 Dihydrochloride for Stem Cell Assays

  2026-09-14

  Use Y-27632 dihydrochloride as a selective ROCK perturbation tool to separate cell-survival, cytoskeletal, and adhesion effects in pluripotent stem cell workflows. Its strongest value is not simply improving attachment, but enabling controlled comparisons in interspecies adhesion assays, stem cell handling, and invasion-focused cancer research.

• A 83-01 ALK-5 Inhibitor: Workflow Guide

  2026-09-14

  A 83-01 enables controlled interrogation of TGF-β/Smad signaling in EMT, organoid, fibrosis, and growth-inhibition assays. This practical guide connects receptor-selective pharmacology with the WNT-driven biliary injury model reported in a recent JCI Insight study, while emphasizing dose control, orthogonal readouts, and troubleshooting.

• Eltanexor and the Strategic Future of XPO1 Research

  2026-09-13

  Eltanexor (KPT-8602) turns XPO1 inhibition into a translational research strategy spanning acute myeloid leukemia, lymphomas, and colorectal cancer models. This article connects nuclear export biology with experimental design, evidence maturity, formulation discipline, and the next questions for cancer therapeutics targeting nuclear export.

• Gallein: G Protein βγ Inhibitor Workflows

  2026-09-12

  Gallein provides a practical perturbation tool for separating G protein βγ-dependent signaling from receptor-specific effects in metabolic, cancer, immune, and cardiac assays. Its strongest value is comparative: the same inhibitor can support acute pathway dissection in cells while informing translational models, provided dose, viability, and pathway-specific controls are built into the workflow.

• DiscoveryProbe Stem Cell Compound Library Plus Guide

  2026-09-11

  Turn pathway breadth into interpretable stem cell phenotypes with a 280-compound collection spanning self-renewal, differentiation, proliferation, and disease-relevant signaling. This guide pairs the L1040P stem cell compound library with high-content imaging, orthogonal validation, and troubleshooting strategies that help separate genuine pathway effects from nonspecific toxicity.

• Triiodothyronine at the Beige-Fat Frontier

  2026-09-11

  A translational perspective on how Triiodothyronine and T3 can be used to interrogate thyroid hormone receptor activation, beige adipocyte biology, and metabolic disease mechanisms alongside emerging SEMA3E–β-catenin evidence.

• 4-MUG: A Functional Readout for Lysosomal GCase

  2026-09-10

  4-Methylumbelliferyl-β-D-Glucopyranoside converts β-glucosidase activity into a quantitative fluorescent signal. This guide explains how to use 4-MUG to interpret lysosomal function, GBA1 mRNA rescue, and Gaucher disease models without confusing enzyme abundance with catalytic performance.

• Triamcinolone (B1859): Practical Research Workflow

  2026-09-10

  Triamcinolone (SKU B1859) provides a high-purity synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solvent selection, stock handling, controls, and quality checks; the material is not intended for diagnostic, therapeutic, clinical, or unsupported in vivo use.

• RepSox for iPSC Platelet Differentiation

  2026-09-09

  RepSox provides a precise way to test ALK5-dependent TGF-β signaling during iPSC reprogramming and platelet-lineage differentiation. This evidence-aware workflow combines a reported 25 μM, 3-day exposure with the latest high-yield megakaryocyte protocol to separate validated findings from experiments that still require optimization.

• Gemcitabine Workflows for DNA Damage Research

  2026-09-09

  Gemcitabine enables controlled studies of DNA synthesis inhibition, checkpoint activation, and apoptosis across cancer models. This workflow connects practical dosing and assay design with the TAK1–YAP stemness findings reported in gastric cancer research, while clearly separating established evidence from hypothesis-generating applications.

• Triamcinolone Research Workflow and QC Guide

  2026-09-08

  Triamcinolone provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solvent selection, stock preparation, storage, and assay controls; the compound is for scientific research only and must not be used for diagnostic, therapeutic, or clinical purposes.

8416 records 1/562 page Next 12345 下5页 Last page